billS4036Event Tuesday, March 10, 2026Analyzed

AADAPT Act

Neutral

Summary

The AADAPT Act (S4036) is an early-stage Senate bill that amends the Project ECHO Grant Program to include dementia and Alzheimer's care training. It authorizes no specific funding and has not yet passed a single committee vote. While related House bill HR3747 has advanced further (Union Calendar status), there are no direct revenue impacts on any specific publicly traded company at this stage.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.S4036 is a bill to expand an existing grant program for dementia care training, with no authorized funding amount.
  • 2.The House companion (HR3747) has advanced out of committee; it is the more viable path for enactment.
  • 3.Until actual appropriations occur, this bill has zero material revenue impact on any publicly traded company.
  • 4.Pure-play dementia diagnostics/therapeutics companies ($LLY, $BIIB, $ACAD, $ANVS) remain driven by drug trial data, FDA decisions, and CMS coverage policy—not by tele-education grant program expansions.

Market Implications

This bill does not change the competitive landscape for any sector. Dementia drug developers ($LLY, $BIIB, $ACAD, $ANVS) are unaffected—CMS coverage of Alzheimer's drugs (donanemab, lecanemab) is a far larger catalyst. Senior care REITs ($WELL, $OHI) and hospital operators ($HCA, $UHS) are also unaffected; dementia training grants are a minor operational cost offset. The bill is a procedural positive for the dementia awareness theme but offers no trading catalyst.

Full Analysis

Senator Capito (R-WV) introduced S4036 on March 10, 2026, with seven bipartisan cosponsors. The bill was read twice and referred to the Senate HELP Committee. It amends Section 330N of the Public Health Service Act to expand an existing grant program—Project ECHO—to disseminate knowledge on dementia care. This is a capacity-building and knowledge-sharing bill, not a direct procurement or reimbursement measure. No dollar amount is authorized or appropriated. The House companion, HR3747, has advanced further: it was placed on the Union Calendar (Calendar No. 628), meaning it passed out of committee and is ready for floor consideration. This increases the probability that the AADAPT Act's language will advance via the House bill, but the Senate version remains at square one. No tickers are warranted because the bill does not create a revenue-generating mechanism for any single company. The Project ECHO model is a grant-funded tele-mentoring program—grants go to hospitals, universities, and nonprofit entities, not publicly traded companies in a material way. The program's budget is small (historically ~$30M annually across all Project ECHO grants, not just dementia). For $UNH ($371.6B revenue), $HCA ($65B), or any listed healthcare provider, a grant for dementia training is effectively zero. The convergence with HR3747 confirms the legislative lane is real, but the financial impact is essentially nil until an appropriations bill provides specific funding for a new dementia-focused grant stream.

Key Legislators

Sen. Capito, Shelley Moore [R-WV]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →